INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹256 Cr | ₹205 Cr | ₹194 Cr | ₹88 Cr | ₹44 Cr |
What is the latest Total Non-Current Liabilities ratio of INNOVA CAPTAB ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹256 Cr |
| Mar2024 | ₹205 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹88 Cr |
| Mar2021 | ₹44 Cr |
How is Total Non-Current Liabilities of INNOVA CAPTAB Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹256 Cr | 25.03 | |
| Mar2024 | ₹205 Cr | 5.35 | |
| Mar2023 | ₹194 Cr | 120.40 | |
| Mar2022 | ₹88 Cr | 97.99 | |
| Mar2021 | ₹44 Cr | - | |
Compare Total Non-Current Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,875.9 Cr | -5% | -0.3% | -25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -5% |
-0.3% |
-25.5% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses